PUBLIC COMPANY

$ELDNEledon Pharmaceuticals, Inc.

Irvine, CA, USupdated 1mo ago

SEC EDGAR Yahoo Finance

community read0 votes

pipeline

1

marketed

0

phase 3

0

catalysts ytd

0

approvals ytd

0

recalls ytd

0

Pipeline(1)

pipeline depth1 products

1Phase 2

Phase 2

tegoprubart

Pancreatic Islet Transplant Rejection

CD40 ligand

Upcoming

no upcoming catalysts on record

Recent(90d)

nothing in the last 90 days

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view Eledon Pharmaceuticals, Inc. jobs →

News

no news has mentioned this company yet

Active trials

phase2Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipientsenrolling by invitationn=132
phase2Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantationcompletedn=127
phase2Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplantrecruitingn=48
phase2Safety and Efficacy of AT-1501 in Patients With IgA Nephropathy (IgAN)terminatedn=24

$ELDN

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

SEC EDGAR

last refreshed 2m ago

Found something off?